Moreover, linear regression analyses showed that higher Gpr132 expression was significantly correlated with higher expression of pro-inflammatory markers including CCL2 (MCP-1), MMP9 and PTGS2 (COX-2) in breast cancer lesions (Figure 4F). This evidence concerns the gene GPR132 and breast carcinoma.